| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.00031 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 2.8e-05 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 1.9e-05 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -1.5e-05 | 1 |